Tracy Read

Tracy Read currently serves as a Principal Clinical Trial Administrator, Trainer, and Mentor at Galderma since July 2014, where responsibilities include assisting the Chief Medical Officer and Head of Galderma HR with the closure of the Princeton Facility and overseeing the transfer of employees and operations to the new Galderma R&D in Ft. Worth, Texas. Prior to this role, Tracy Read held various positions at Alcon Laboratories, Inc. from February 1991 to July 2014, including Aesthetic & Corrective Coordinator and Executive Administrative Professional. Tracy Read is expected to achieve certification from the American Board of Neuro-Linguistic in May 2024.